Canada markets open in 2 hours 30 minutes

The Cooper Companies, Inc. (COO)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
406.17+6.20 (+1.55%)
At close: 04:02PM EST
406.17 0.00 (0.00%)
After hours: 04:15PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close399.97
Open402.20
Bid405.27 x 900
Ask406.18 x 900
Day's Range401.39 - 409.23
52 Week Range337.40 - 463.59
Volume289,046
Avg. Volume272,822
Market Cap20.026B
Beta (5Y Monthly)0.86
PE Ratio (TTM)6.87
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.06 (0.02%)
Ex-Dividend DateJul. 26, 2021
1y Target EstN/A
All
News
  • GlobeNewswire

    CooperCompanies Announces Fourth Quarter and Full Year 2021 Results

    SAN RAMON, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for its fiscal fourth quarter and full year ended October 31, 2021. Fourth quarter revenue increased 11% year-over-year to $759.1 million. Fiscal 2021 revenue increased 20% to $2,922.5 million.Fourth quarter GAAP diluted earnings per share (EPS) $2.21, up 57 cents or 35% from last year's fourth quarter. Fiscal 2021 GAAP diluted EPS $59.16, up 1,131% from fiscal 2020.Fourth quarter

  • GlobeNewswire

    CooperCompanies Announces Executive Management Changes

    Dan McBride to Take on Expanded Responsibilities as EVP, Chief Operating Officer Jerry Warner Promoted to President, CooperVision SAN RAMON, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced two senior leadership changes that will enable the company to maximize current and future opportunities. Effective February 1, 2022, Dan McBride, Executive Vice President (EVP), Chief Operating Officer of CooperCompanies, will take on additional responsibilities that span

  • GlobeNewswire

    CooperCompanies to Acquire Generate Life Sciences® for $1.6 Billion

    Acquisition will Expand CooperSurgical’s Fertility and Labor & Delivery OfferingsSAN RAMON, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced that it has signed a definitive purchase agreement to acquire Generate Life Sciences, a privately held leading provider of donor egg and sperm for fertility treatments, fertility cryopreservation services and newborn stem cell storage (cord blood & cord tissue). “This acquisition is a strong strategic fit for CooperSurgi